Comparison of resveratrol supplementation, calorie restriction diet and placebo on nutritional status, metabolic and oxidative parameters, serum sirtuin-1 and fibroblast growth factor-21 levels in patients with nonalcoholic fatty liver disease

utrition Research Center, vice-chancellor of Tabriz University of Medical Sciences0 个研究点目标入组 87 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•age between 20 to 60 years from both gender; diagnosed with nonalcoholic fatty liver disease based on liver Ultrasonography; BMI=25-35; willingness to participate in the study.
•Exclusion criteria: pregnancy; breast feeding and postmenopausal women; professional athletes; smoking; alcohol consumption; following weight-reducing diet 3 months prior to the study; known liver disease (viral/etc.); inherited disorders affecting the liver; history of diagnosed cardiovascular, kidney, diabetes, gastrointestinal, pulmonary and autoimmune diseases, thyroid dysfunction and active cancer; recent surgery; use of medications such as corticosteroids, hepatotoxic drugs, hormonal drugs (such as oral contraceptive and/or estrogens), antidepressants and psychotropic medications, anticoagulant drugs, oral anti-diabetic and lipid-lowering drugs. Receiving any kinds of supplements 3 months prior to the study.

发起方

utrition Research Center, vice-chancellor of Tabriz University of Medical Sciences